Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 82-88, January 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Testa, U.
Right arrow Articles by Thang, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Testa, U.
Right arrow Articles by Thang, M. N.

Effect of Endogenous and Exogenous Interferons on the Differentiation of Human Monocyte Cell Line U9371

Ugo Testa, Didier Ferbus2, Marco Gabbianelli, Brunella Pascucci, Giovanni Boccoli, Fawzia Louache and Ming Nguy Thang

INSERM, Unité 245 et Centre National de la Recherche Scientifique, U.A.C. 113, Center INSERM, Hôpital St-Antoine, 184, rue du Faubourg St-Antoine, 75571 Paris Cédex 12, France; INSERM, Unité 91, Hôpital Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Creteil, France; and Instituto Superiore di Sanita, Laboratorio di Ematologia, Viale Regina Elena, 299-00161 Roma, Italy

The effect of interferons (IFNs) on the differentiation of hematopoietic cells was examined with the human monocyte cell line U937. The differentiation of U937 was induced by hydroxyvitamin D3 and was evaluated through the study of specific markers.

The induction of the U937 differentiation was associated with a production of IFN and with a marked increase in (2'5') oligoadenylate synthetase. Addition of anti-IFN-{alpha}/ß antibodies inhibited the enhancement of (2'5') oligoadenylate synthetase and reduced the inhibitory effect of hydroxyvitamin D3 on cell growth. Nevertheless, neutralization of endogenous IFN excreted during U937 cell maturation did not modify the expression of the differentiation markers examined. Exogenous natural IFN-{alpha}, IFN-ß, or recombinant (r) IFN-{gamma}, when added to the culture medium, did not promote a "global" U937 differentiation. Most of the differentiation markers, except for reduction of nitroblue-tetrazolium, were not induced by IFN-{alpha} or -ß. However, rIFN-{gamma} was able to induce the appearance of several monocytic membrane markers at an extent comparable or slightly inferior to that elicited by hydroxyvitamin D3. Different effects on the expression of HLA antigens were obtained with these IFNs: IFN-{alpha} or -ß enhanced mainly class I HLA antigen expression, whereas rIFN-{gamma} increased selectively the expression of class II HLA DC1 but not HLA DR antigens. In contrast, phytohemagglutinin-leukocyte conditioned medium elicited a marked and selective enhancement of the expression of HLA-DR antigens. This induction of HLA DC1 antigens by rIFN-{gamma} was not observed in two other leukemic cell lines (HL60 and HEL). The present study shows that IFN-{alpha} or -ß may participate in the antiproliferative effect occurring during cellular differentiation, while IFN-{gamma} may be involved in the induction of the expression of specific monocytic markers involved in cellular immunoregulation.

1 This research was supported in part by grants from INSERM (U.245, U.91), Centre National de la Recherche Scientifique (U.A.C. 113), Fondation pour la Recherche Médicale, and Associazione Italiana per la Ricerca sul Cancro.

2 To whom requests for reprints should be addressed, at U.245 INSERM, Centre INSERM, Hôpital St-Antoine, 184, rue du Faubourg St-Antoine, 75571 Paris Cédex 12, France.

Received 3/17/87. Revised 9/14/87. Accepted 9/30/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.